Botryoid rhabdomyosarcoma of the nasopharynx.
A case report of a Stage III botryoid rhabdomyosarcoma of the nasopharynx associated with a six-and-a-half-year survival is presented. Treatment consisted of surgery, radiotherapy (6,000 rads TCT) to the nasopharynx and maxillary sinuses bilaterally, and six cycles of polychemotherapy with Vincristine, Adriamycin, Cyclophosphamide and DTIC, without major loss of function or cosmetic deformity. The histology of the lesion is discussed with reference to recent classification and prognosis. The authors suggest that the histological type and prognosis of rhabdomyosarcoma of the nasopharynx in children may be better correlated in future studies.
D002648:Child; D005260:Female; D006801:Humans; D009303:Nasopharyngeal Neoplasms / Q000473:pathology* / Q000628:therapy; D011379:Prognosis; D012208:Rhabdomyosarcoma / Q000473:pathology* / Q000628:therapy